IQE plc: Director/PDMR Shareholding

IQE plc

Cardiff, UK
16 February 2022

Director/PDMR Shareholding

IQE plc (AIM: IQE, "IQE" or the "Group"), the leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry, was notified on 15 February 2022 that on that date Dr Drew Nelson, President and Non-Executive of the Company, purchased 4,126,817 ordinary shares of 1 pence each in the Company (“Ordinary Shares”).

This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the Person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”)
a)	Name	Dr Drew Nelson
2.	Reason for the notification
a)	Position / status	PDMR (President and Non-Executive Director)
b)	Initial notification / amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	IQE plc
b)	Legal Entity Identifier	213800Y33WHD3ESJJP16
4.	Details of the transaction(s): section to be repeated for ( i ) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Ordinary shares of 1 pence each in the Company GB0009619924
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	4,126,817 Ordinary Shares at an average price of 36.36p per Ordinary Share
d)	Aggregated information  Aggregated volume  Aggregated price	Aggregated volume: 4,126,817 Aggregated price: £1,500,510.66
e)	Date of the transaction(s)	15 February 2022
f)	Place of the transaction	London Stock Exchange, AIM (AIMX)

Contacts:

IQE plc
[phone]
Americo Lemos
Tim Pullen
Amy Barlow
        
Peel Hunt LLP (Nomad and Joint Broker)
[phone]
Edward Knight
Paul Gillam
James Smith
        
Citigroup Global Markets Limited (Joint Broker)
[phone]
Christopher Wren
Peter Catterall        

Headland Consultancy (Financial PR)
+ 44 (0) 20 38054822
Andy Rivett-Carnac: [phone]
Chloe Francklin: [phone]

ABOUT IQE

http://iqep.com

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

• handset devices
• global telecoms infrastructure
• connected devices
• 3D sensing

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the whole market and is agnostic to the winners and losers at chip and OEM level. By leveraging the Group’s intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with c. 670 employees across nine manufacturing locations in the UK, US, Taiwan and Singapore, and is listed on the AIM Stock Exchange in London.